Cart
sales@molnova.com
Licraside
CAS No. 29913-71-1
Licraside( Licuraside )
Catalog No. M26739 CAS No. 29913-71-1
Licraside is a tyrosinase inhibitor with an IC50 of 0.072 mM for monophenolase and can be used in studies about antibrowning and depigmenting agents.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 250 | Get Quote |
|
| 10MG | 410 | Get Quote |
|
| 25MG | 662 | Get Quote |
|
| 50MG | 888 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLicraside
-
NoteResearch use only, not for human use.
-
Brief DescriptionLicraside is a tyrosinase inhibitor with an IC50 of 0.072 mM for monophenolase and can be used in studies about antibrowning and depigmenting agents.
-
DescriptionLicraside is a tyrosinase inhibitor with an IC50 of 0.072 mM for monophenolase and can be used in studies about antibrowning and depigmenting agents.
-
In Vitro——
-
In Vivo——
-
SynonymsLicuraside
-
PathwayProteasome/Ubiquitin
-
TargetTyrosinase
-
RecptorMAO-B
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number29913-71-1
-
Formula Weight550.513
-
Molecular FormulaC26H30O13
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 100 mg/mL (181.65 mM)
-
SMILES[H][C@]1(O[C@@H]2OC[C@](O)(CO)[C@H]2O)[C@H](Oc2ccc(C(=O)\C=C\c3ccc(O)cc3)c(O)c2)O[C@H](CO)[C@@H](O)[C@@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Tzvetkov NT, et al. Indazole- and indole-5-carboxamides: selective and reversible monoamine oxidase B inhibitors with subnanomolar potency. J Med Chem. 2014 Aug 14;57(15):6679-703.
molnova catalog
related products
-
GTP-14564
GTP-14564 is a novel tyrosine kinase inhibitor that also inhibits wt-FLT3 and ITD-FLT3.
-
Arbutin
Arbutin(β-Arbutin) is a glycoside; a glycosylated hydroquinone extracted from the bearberry plant in the genus Arctostaphylos; inhibits tyrosinase and thus prevents the formation of melanin.
-
Flanvotumab
Flanvotumab (IMC-20D7S) is a humanized monoclonal antibody targeting tyrosinase-related protein (TYRP1), exhibiting potent antitumor activity through natural killer-mediated and antibody-dependent cell-mediated cytotoxicity (ADCC).
